|
GPATCH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20420023847134E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55150003955384E-09 |
| Normal-vs-Stage2 |
3.16979997805333E-10 |
| Normal-vs-Stage3 |
8.38710212391902E-11 |
| Normal-vs-Stage4 |
5.97700000604107E-09 |
| Stage1-vs-Stage2 |
1.461400E-01 |
| Stage1-vs-Stage3 |
1.211970E-01 |
| Stage1-vs-Stage4 |
5.979400E-01 |
| Stage2-vs-Stage3 |
7.554600E-01 |
| Stage2-vs-Stage4 |
4.390600E-01 |
| Stage3-vs-Stage4 |
5.457600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.3253999554006E-10 |
| Normal-vs-AfricanAmerican |
1.762470E-03 |
| Normal-vs-Asian |
7.50119999448629E-09 |
| Caucasian-vs-AfricanAmerican |
3.875700E-02 |
| Caucasian-vs-Asian |
8.500200E-01 |
| AfricanAmerican-vs-Asian |
7.674100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41959946207282E-10 |
| Normal-vs-Female |
3.50199980125865E-10 |
| Male-vs-Female |
9.431400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61449994987117E-09 |
| Normal-vs-Age(41-60Yrs) |
1.05209951861696E-10 |
| Normal-vs-Age(61-80Yrs) |
1.22520005252369E-09 |
| Normal-vs-Age(81-100Yrs) |
1.196400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.361220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.217000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.314200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.828000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.370800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.715200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.31799999999005E-05 |
| Classical-VS-Follicular |
5.480100E-02 |
| Classical-VS-Other |
7.578800E-01 |
| Classical-VS-Normal |
1.5854999979581E-08 |
| Tall-VS-Follicular |
4.188100E-02 |
| Tall-VS-Other |
1.082380E-01 |
| Tall-VS-Normal |
3.37407879413831E-12 |
| Follicular-VS-Other |
7.592200E-01 |
| Follicular-VS-Normal |
9.79599956707489E-10 |
| Other-VS-Normal |
1.013590E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.71089833808946E-11 |
| Normal-vs-N1 |
4.76470000121409E-08 |
| N0-vs-N1 |
2.597000E-01 |
|
|
